PortalPublikationenCirculating Tumour Cells, Circulating Tumour DNA and Circula...

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?

Standard

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer? / Polasik, Arkadius; Tzschaschel, Marie; Schochter, Fabienne; de Gregorio, Amelie; Friedl, Thomas W P; Rack, Brigitte; Hartkopf, Andreas; Fasching, Peter A; Schneeweiss, Andreas; Müller, Volkmar; Huober, Jens; Janni, Wolfgang; Fehm, Tanja.

in: GEBURTSH FRAUENHEILK, Jahrgang 77, Nr. 12, 12.2017, S. 1291-1298.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Polasik, A, Tzschaschel, M, Schochter, F, de Gregorio, A, Friedl, TWP, Rack, B, Hartkopf, A, Fasching, PA, Schneeweiss, A, Müller, V, Huober, J, Janni, W & Fehm, T 2017, 'Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?', GEBURTSH FRAUENHEILK, Jg. 77, Nr. 12, S. 1291-1298. https://doi.org/10.1055/s-0043-122884

APA

Polasik, A., Tzschaschel, M., Schochter, F., de Gregorio, A., Friedl, T. W. P., Rack, B., Hartkopf, A., Fasching, P. A., Schneeweiss, A., Müller, V., Huober, J., Janni, W., & Fehm, T. (2017). Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer? GEBURTSH FRAUENHEILK, 77(12), 1291-1298. https://doi.org/10.1055/s-0043-122884

Vancouver

Polasik A, Tzschaschel M, Schochter F, de Gregorio A, Friedl TWP, Rack B et al. Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer? GEBURTSH FRAUENHEILK. 2017 Dez;77(12):1291-1298. https://doi.org/10.1055/s-0043-122884

Bibtex

@article{b9a2d518cc4a4f9088a58d269d905271,
title = "Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?",
abstract = "Dissemination of tumour cells and the development of solid metastases occurs via blood vessels and lymphatics. Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) can be detected in venous blood in patients with early and metastatic breast cancer, and their prognostic relevance has been demonstrated on numerous occasions. Repeated testing for CTCs and ctDNA, or regular so-called {"}liquid biopsy{"}, can be performed easily at any stage during the course of disease. Additional molecular analysis allows definition of tumour characteristics and heterogeneity that may be associated with treatment resistance. This in turn makes personalised, targeted treatments possible that may achieve both improved overall survival and quality of life.",
keywords = "Journal Article",
author = "Arkadius Polasik and Marie Tzschaschel and Fabienne Schochter and {de Gregorio}, Amelie and Friedl, {Thomas W P} and Brigitte Rack and Andreas Hartkopf and Fasching, {Peter A} and Andreas Schneeweiss and Volkmar M{\"u}ller and Jens Huober and Wolfgang Janni and Tanja Fehm",
year = "2017",
month = dec,
doi = "10.1055/s-0043-122884",
language = "English",
volume = "77",
pages = "1291--1298",
journal = "GEBURTSH FRAUENHEILK",
issn = "0016-5751",
publisher = "Georg Thieme Verlag KG",
number = "12",

}

RIS

TY - JOUR

T1 - Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?

AU - Polasik, Arkadius

AU - Tzschaschel, Marie

AU - Schochter, Fabienne

AU - de Gregorio, Amelie

AU - Friedl, Thomas W P

AU - Rack, Brigitte

AU - Hartkopf, Andreas

AU - Fasching, Peter A

AU - Schneeweiss, Andreas

AU - Müller, Volkmar

AU - Huober, Jens

AU - Janni, Wolfgang

AU - Fehm, Tanja

PY - 2017/12

Y1 - 2017/12

N2 - Dissemination of tumour cells and the development of solid metastases occurs via blood vessels and lymphatics. Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) can be detected in venous blood in patients with early and metastatic breast cancer, and their prognostic relevance has been demonstrated on numerous occasions. Repeated testing for CTCs and ctDNA, or regular so-called "liquid biopsy", can be performed easily at any stage during the course of disease. Additional molecular analysis allows definition of tumour characteristics and heterogeneity that may be associated with treatment resistance. This in turn makes personalised, targeted treatments possible that may achieve both improved overall survival and quality of life.

AB - Dissemination of tumour cells and the development of solid metastases occurs via blood vessels and lymphatics. Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) can be detected in venous blood in patients with early and metastatic breast cancer, and their prognostic relevance has been demonstrated on numerous occasions. Repeated testing for CTCs and ctDNA, or regular so-called "liquid biopsy", can be performed easily at any stage during the course of disease. Additional molecular analysis allows definition of tumour characteristics and heterogeneity that may be associated with treatment resistance. This in turn makes personalised, targeted treatments possible that may achieve both improved overall survival and quality of life.

KW - Journal Article

U2 - 10.1055/s-0043-122884

DO - 10.1055/s-0043-122884

M3 - SCORING: Review article

C2 - 29269956

VL - 77

SP - 1291

EP - 1298

JO - GEBURTSH FRAUENHEILK

JF - GEBURTSH FRAUENHEILK

SN - 0016-5751

IS - 12

ER -